Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Madan

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Plos One|November 28, 2012
Lactobacillus proteins are associated with the bactericidal activity against E. coli of female genital tract secretionsSabah Kalyoussef, Edward Nieves, Ellen Dinerman, et al.
Plos One|January 29, 2010
Postcoital bioavailability and antiviral activity of 0.5% PRO 2000 gel: implications for future microbicide clinical trialsMarla J Keller, Pedro M M Mesquita, N Merna Torres, et al.
Plos One|February 2, 2011
A randomized trial to assess anti-HIV activity in female genital tract secretions and soluble mucosal immunity following application of 1% tenofovir gelMarla J Keller, Rebecca P Madan, N Merna Torres, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Plos One|November 28, 2012
Lactobacillus proteins are associated with the bactericidal activity against E. coli of female genital tract secretionsSabah Kalyoussef, Edward Nieves, Ellen Dinerman, et al.
Plos One|January 29, 2010
Postcoital bioavailability and antiviral activity of 0.5% PRO 2000 gel: implications for future microbicide clinical trialsMarla J Keller, Pedro M M Mesquita, N Merna Torres, et al.
Plos One|February 2, 2011
A randomized trial to assess anti-HIV activity in female genital tract secretions and soluble mucosal immunity following application of 1% tenofovir gelMarla J Keller, Rebecca P Madan, N Merna Torres, et al.
Pageof 4